(EMAILWIRE.COM, January 25, 2019 ) The major factors driving the growth of hydrophobic interaction chromatography market are the increasing demand for monoclonal antibodies and increasing R&D expenditure in biopharmaceuticals.

Monoclonal antibodies likely to drive the market
In the past decade, there has been a significant increase in the demand for mAbs not only in oncology but several other therapeutic areas such as Alzheimer’s, autoimmune diseases, and inflammatory disorders. These therapeutic areas have also gained prominence in recent years, as a result of which, almost all major pharmaceutical companies have undertaken R&D on therapeutic antibodies. In the purification of mAbs, impurities and aggregates are removed through different chromatography resins, including hydrophobic interaction chromatography resins. In drug discovery applications, hydrophobic interaction chromatography plays an important role in capturing and polishing target proteins during the purification process.

Hydrophobic interaction chromatography is widely used for mAbs purification. Therefore, the increase in the number of mAbs approvals will eventually drive the demand for hydrophobic interaction chromatography resins.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=200633435

In 2018, North America is expected to account for the largest share of the global hydrophobic interaction chromatography market. The availability of government and public funding for protein-based research projects, increased adoption of automated purification instruments, high demand for protein biologics, and increasing R&D efforts by pharmaceutical and biotechnology companies are some of the major factors driving the growth of the HIC market in North America.